Literature DB >> 7301635

In vitro stimulation of prolactin release by vasoactive intestinal peptide.

W K Samson, S I Said, G Snyder, S M McCann.   

Abstract

The effect of vasoactive intestinal peptide (VIP) on anterior pituitary hormone release was examined in a variety of in vitro preparations. Synthetic VIP was capable of stimulating increased prolactin (PRL) release from male rat hemipituitaries in doses as low as 10-9M only when the enzyme inhibitor bacitracin was present in the incubation medium. Natural porcine VIP was similarly capable of stimulating PRL release, but only at higher doses (10-6M). Additionally, synthetic VIP was capable of stimulating PRL release from dispersed anterior pituitary cells harvested from adult male and lactating female rats and from an enriched population of lactotrophs obtained by unit gravity sedimentation of similar dispersed cells from infantile female rats. No effect of VIP on luteinizing hormone, growth hormone or thyroid stimulating hormone release was seen. These findings taken in concert with the presence of VIP in the hypothalamus, pituitary and hypophyseal portal plasma of the rat suggest a physiological role for VIP in the control of PRL secretion.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7301635     DOI: 10.1016/0196-9781(80)90010-8

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  13 in total

Review 1.  Ontogenic studies of the neural control of adenohypophyseal hormones in the rat. II. Prolactin.

Authors:  D Becú-Villalobos; I M Lacau-Mengido; G S Díaz-Torga; C Libertun
Journal:  Cell Mol Neurobiol       Date:  1992-02       Impact factor: 5.046

2.  HIV gp120 inhibits the somatotropic axis: a possible GH-releasing hormone receptor mechanism for the pathogenesis of AIDS wasting.

Authors:  S E Mulroney; K J McDonnell; C B Pert; M R Ruff; Z Resch; W K Samson; M D Lumpkin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

3.  Vasoactive intestinal peptide in the human pituitary gland and adenomas. An immunocytochemical study.

Authors:  D W Hsu; P N Riskind; E T Hedley-Whyte
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

4.  Immunohistochemical localization of vasoactive intestinal peptide (VIP) in the circumventricular organs of the rat.

Authors:  J D Mikkelsen
Journal:  Cell Tissue Res       Date:  1989-02       Impact factor: 5.249

5.  A novel reproductive peptide, phoenixin.

Authors:  G L C Yosten; R-M Lyu; A J W Hsueh; O Avsian-Kretchmer; J-K Chang; C W Tullock; S L Dun; N Dun; W K Samson
Journal:  J Neuroendocrinol       Date:  2013-02       Impact factor: 3.627

6.  Vasoactive intestinal polypeptide modulates the estradiol-induced prolactin surge by entraining oxytocin neuronal activity.

Authors:  Jessica E Kennett; Maristela O Poletini; Marc E Freeman
Journal:  Brain Res       Date:  2008-01-03       Impact factor: 3.252

7.  Neuropeptide Y affects secretion of luteinizing hormone and growth hormone in ovariectomized rats.

Authors:  J K McDonald; M D Lumpkin; W K Samson; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

8.  Adenosine 3',5'-cyclic monophosphate-dependent release of prolactin from GH3 pituitary tumour cells. A quantitative analysis.

Authors:  S Guild; A H Drummond
Journal:  Biochem J       Date:  1983-12-15       Impact factor: 3.857

Review 9.  The role of vasoactive intestinal polypeptide (VIP) as a hypothalamic neurohormone.

Authors:  S Nicosia; D Oliva; G Giannattasio; A Spada
Journal:  J Endocrinol Invest       Date:  1983-06       Impact factor: 4.256

10.  Neuronostatin encoded by the somatostatin gene regulates neuronal, cardiovascular, and metabolic functions.

Authors:  Willis K Samson; Jian V Zhang; Orna Avsian-Kretchmer; Kai Cui; Gina L C Yosten; Cindy Klein; Rong-Ming Lyu; Yong Xiong Wang; Xiang Qun Chen; Jun Yang; Christopher J Price; Ted D Hoyda; Alastair V Ferguson; Xiao-bin Yuan; Jaw Kang Chang; Aaron J W Hsueh
Journal:  J Biol Chem       Date:  2008-08-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.